Clinical Trials Logo

Skin Disease clinical trials

View clinical trials related to Skin Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT05561595 Not yet recruiting - Obesity Clinical Trials

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

HEARTS
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Stigma due to health conditions increases disease burden and adversely impacts health. The internalization of health-related stigma is associated with impaired mental health and quality of life. The current project will test the effects of a novel, transdiagnostic, group counseling intervention, and peer support, to determine the optimal method for helping patients cope with health-related stigma, reducing its internalization, and enhancing patient quality of life.

NCT ID: NCT02663921 Completed - Skin Disease Clinical Trials

Visible Light Study

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about the potential effects of visible light on the skin. More specifically, this study will examine whether an incandescent lamp (light bulb) or LED light bulb can cause skin to become darker. Investigators will determine the minimum threshold dose required to achieve immediate pigmentation darkening (IPD), persistent pigmentation darkening (PPD), and delayed tanning (DT) for Fitzpatrick skin types IV - VI utilizing two visible light sources.

NCT ID: NCT02465476 Completed - Skin Disease Clinical Trials

Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine

Telemalrares
Start date: January 6, 2015
Phase: N/A
Study type: Interventional

The investigators want to demonstrate that a new organization with telemedicine could rationalize the treatment pathway of patient suffering from rare skin disease. A diagnosis and a personalised treatment pathway could be performed before the consultation in the hospital.

NCT ID: NCT02338076 Completed - Skin Disease Clinical Trials

A Study to Document the Effect of Petrolatum on Innate Immune Responses in the Skin

Start date: June 2013
Phase: N/A
Study type: Interventional

Petrolatum is a very well-known emollient that has been used since the 1800's. Not only has it been used to help with dry skin, but it is also marketed as a substance that protects minor cuts and burns. In the past it was thought to be inferior to topical antibiotics in infection prevention for cutaneous wounds. However, in 1996 a large, multicenter trial including over 900 patients showed that petrolatum is as safe and effective as the topical antibiotic, bacitracin in preventing infections for patients undergoing dermatological surgery. In this trial, not only did the petrolatum group have similarly low rates of infection, this group also reported no cases of contact dermatitis. Aside from being more expensive than petrolatum, bacitracin and other topical antimicrobials (i.e. neomycin) have been known as common culprits of contact dermatitis. In a study done by the North American Contact Dermatitis Group between 2005-2006, 9.2 and 10% of the over 4,000 patients who were patch tested had an allergic reaction to either bacitracin or neomycin, respectively. For the above reasons, it is clear that petrolatum is an appealing alternative to topical antibiotics for infection prevention in patients undergoing dermatological procedures. This study however lacked any mechanistic analyses to provide molecular insight as to how petrolatum was effective at infection prevention. The aim of this research is to study the effect of petrolatum on innate immune reactions in the skin. In particular, petrolatum's effect on various antimicrobial peptides after contact with the skin for 3 days will be examined. This will be done through immunohistochemistry for various cellular infiltrates as well as mRNA gene expression via RT-PCR analysis for inflammatory and AMP genes. Tissue samples of petrolatum occluded skin will be compared to both healthy skin and skin under occlusion alone as controls. These comparisons will isolate the effect of the petrolatum on the skin.

NCT ID: NCT02309905 Completed - Skin Disease Clinical Trials

Evaluation of Tele-expertise for Inmates With a Dermatological Lesion

TLM-Inmates
Start date: June 2014
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether Tele-expertise would be effective and cost-effective by reducing the number of secure transportations for inmates in need of a dermatological consultation

NCT ID: NCT01187732 Completed - Skin Disease Clinical Trials

Washing Without Water: Cost-effectiveness of a Rapidly Spreading Nursing Intervention in Bedridden Patients'

WWW
Start date: April 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the traditional bed bath with 'washing without water' on - 1) effects on skin integrity - 2) patient and nurse satisfaction and 3) costs. In a cluster randomized trial we will randomize 50 nursing home wards (576 patients) to 'washing without water' or traditional bed baths. Bathing regimens are continued for six weeks. Whereas effects on skin damage are not likely to be specific for setting, these results can be generalized to other patient groups.

NCT ID: NCT01012453 Recruiting - Eczema Clinical Trials

A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema

HET
Start date: October 2009
Phase: N/A
Study type: Interventional

Objectives and perspective: 1. To estimate the prevalence of hand eczema in a cohort of health care workers and assess exposures in the hospital environment that can lead to hand eczema . To investigate the knowledge of skin protection among health care workers. 2. To classify subtypes of hand eczema, assess severity of hand eczema and quality of life in health care workers with hand eczema 3. To evaluate the effect of a combination of classification of hand eczema and individual work-related counseling in skin protective behavior. The overall perspective of the trial is to develop new strategies for prevention of occupational hand eczema in health care workers. Hypotheses: - Irritant contact dermatitis is more common than allergic contact dermatitis. - The combination of precise classification (subtyping of HE) and individual counseling will have a positive impact on the prognosis of hand eczema. - The positive impact on the prognosis of hand eczema will have a positive impact on quality of life (QoL). - The knowledge of protective behavior will increase. - Education in a skin care program will have a positive impact on skin protective behavior.

NCT ID: NCT00910260 Completed - Skin Disease Clinical Trials

Impact on UVB Narrow Band and UVA1 Therapy on Serum 25-hydroxyvitamin D Levels

Start date: March 2009
Phase: Phase 4
Study type: Observational

We plan to investigate the serum elevation of 25(OH)D under UVB nb and UVA1 therapy, in order to determine the effect of these nowadays frequently used wavelengths for phototherapy on vitamin D plasma levels. We hope for a better understanding of steady-state and treatment-induced levels of vitamin D changes to better recognize the impact of phototherapy on vitamin D synthesis in the skin, the dimension of vitamin D production to be expected in the course of standard phototherapy and a potential gap in vitamin D production compared to physiological needs which then should be supplemented orally.

NCT ID: NCT00001648 Completed - Herpes Simplex Clinical Trials

Structure of the Herpes Simplex Virus Receptor

Start date: August 20, 1997
Phase: N/A
Study type: Observational

This study will examine the structure of the receptor molecule for the herpes simplex virus (HSV) and determine if the receptor's structure is related to susceptibility to infection with the virus. There are two types of herpes virus-HSV-1 and HSV-2. HSV-1 commonly causes cold sores, and HSV-2 usually causes genital herpes. The herpes virus enters (infects) cells through protein molecules on the cell's surface. This study will explore possible differences between the structure of the HSV receptor molecule in different people to understand better how infection occurs. The study will also look at proteins on white blood cells (Fc receptors, cytokines and mannose binding protein) that may influence the risk of infection with HSV. Information from this study may lead to new treatments to prevent HSV infection. People 18 years of age and older who are infected with HSV and people who are not infected with the virus may be eligible for this study. Participants will have blood drawn to confirm whether or not they have been infected with the virus. The blood sample will also be used to study the genes for the HSV receptor, Fc receptors, cytokines, mannose binding protein and related proteins on the white blood cells. No more than 40 milliliters (8 teaspoons) of blood will be drawn. Participants who are found to have antibodies to HSV-2 will be offered counseling and advice on practicing safe sex techniques to help prevent sexually transmitted diseases, including HSV-2 infection.